US pharma bets big on China to snap up potential blockbuster drugs
By Sriparna Roy and Sneha S K (Reuters) -U.S. drugmakers are licensing molecules from China...
By Sriparna Roy and Sneha S K (Reuters) -U.S. drugmakers are licensing molecules from China...
(Reuters) -Eli Lilly will ship the two highest doses of its popular weight-loss drug Zepbound...
By Joe Brock PARIS (Reuters) -Lockheed Martin and Boeing said on Monday they are positioning...
By Elizabeth Howcroft and John O’Donnell PARIS/FRANKFURT (Reuters) -Two of the world’s largest cryptocurrency companies...
By David Brunnstrom and Michael Martina WASHINGTON (Reuters) -U.S. President Donald Trump told Reuters on...
(Refiles to correct typographical error in paragraph 10) SINGAPORE/NEW YORK (Reuters) -Donald Trump reported more...
WASHINGTON (Reuters) -A gunman posing as a police officer killed a senior Democratic Minnesota lawmaker...
By Lewis Krauskopf NEW YORK (Reuters) -The Federal Reserve’s balancing act between concerns about a...
By Mariam Sunny (Reuters) -Moderna’s shares fell 2.3% on Friday on concerns about whether a...
BEIJING (Reuters) -China has approved 106 new U.S. pork and poultry plants to export eligible...